Oral squamous cell carcinoma: Overview of current understanding of aetiopathogenesis and clinical implications

Oral Diseases

Volumn 15, Issue 6, 2009, Pages 388-399

  Scully, C ^a   Bagan, J V ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Alcohol; Betel; Diet; Genetics; Oral cancer; Tobacco; Viruses

Indexed keywords

BIOLOGICAL MARKER;

ALCOHOL CONSUMPTION; BETEL NUT; CANCER RISK; CARCINOGENESIS; DIETARY INTAKE; DNA REPAIR; GENE MUTATION; GENETIC SUSCEPTIBILITY; HOST RESISTANCE; HUMAN; MOUTH CANCER; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TOBACCO; TUMOR SUPPRESSOR GENE; WART VIRUS;

ASIA, SOUTHEASTERN; CARCINOMA, SQUAMOUS CELL; EUROPE; GENES, TUMOR SUPPRESSOR; HUMANS; MOUTH NEOPLASMS; OTORHINOLARYNGOLOGIC NEOPLASMS; SEX DISTRIBUTION; SOUTH AMERICA; TUMOR MARKERS, BIOLOGICAL;

EID: 68949221111     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2009.01563.x     Document Type: Review

References (201)

1. Abbey LM, Kaugars GE, Gunsolley JC et al (1995). Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80: 188 191.
2. Abnet CC, Kamangar F, Islami F et al (2008). Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17: 3062 3068.
3. Angiero F, Berenzi A, Benetti A et al (2008). Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity. Anticancer Res 28: 2535 2539.
4. Asakage T, Yokoyama A, Haneda T et al (2007). Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. Carcinogenesis 28: 865 874.
5. Bagan JV, Scully C (2009). Recent advances in Oral Oncology 2008; squamous cell carcinoma aetiopathogenesis and experimental studies. Oral Oncol. Feb 2. [Epub ahead of print].
6. Bahar G, Feinmesser R, Shpitzer T et al (2007). Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 109: 54 59.
7. Ball VA, Righi PD, Tejada E et al (1997). p53 immunostaining of surgical margins as a predictor of local recurrence in squamous cell carcinoma of the oral cavity and oropharynx. Ear Nose Throat J 76: 818 823.
8. Bilde A, von Buchwald C, Dabelsteen E et al (2009). Molecular markers in the surgical margin of oral carcinomas. J Oral Pathol Med 38: 72 78.
9. Bloching M, Reich W, Schubert J et al (2007). The influence of oral hygiene on salivary quality in the Ames Test, as a marker for genotoxic effects. Oral Oncol 43: 933 939.
10. Boccia S, Cadoni G, Sayed-Tabatabaei FA et al (2008). CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol 134: 93 100.
11. Boccia S, Hashibe M, Gallì P et al (2009a). Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev 18: 248 254.
12. Boccia S, Boffetta P, Brennan P et al (2009b). Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett 273: 55 61.
13. Boffetta P, Hecht S, Gray N et al (2008). Smokeless tobacco and cancer. Lancet Oncol 9: 667 675.
14. Boldrup L, Coates PJ, Hedberg Y et al (2005). Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers. Int J Oncol 27: 1661 1667.
15. Bouchardy C, Hirvonen A, Coutelle C et al (2000). Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 87: 734 740.
16. Boyle JO, Mao L, Brennan JA et al (1994). Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 168: 429 432.
17. Braakhuis BJ, Tabor MP, Kummer JA et al (2003). A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63: 1727 1730.
18. Braakhuis BJ, Leemans CR, Brakenhoff RH (2004). A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 33: 317 322.
19. Braakhuis BJ, Brakenhoff RH, Leemans CR (2005a). Head and neck cancer: molecular carcinogenesis. Ann Oncol 16 (Suppl 2 ii249 ii250.
20. Braakhuis BJ, Leemans CR, Brakenhoff RH (2005b). Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 15: 113 120.
21. Bray F, Sankila R, Ferlay J et al (2002). Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38: 99 166.
22. Brennan JA, Mao L, Hruban RH et al (1995). Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 429 435.
23. Brinkman BM, Wong DT (2006). Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol 18: 228 233.
24. Brown KS, Kane MA (2006). Chemoprevention of squamous cell carcinoma of the oral cavity. Otolaryngol Clin North Am 39: 349 363.
25. Brunnemann KD, Prokopczyk B, Djordjevic MV et al (1996). Formation and analysis of tobacco-specific N-nitrosamines. Crit Rev Toxicol 26: 121 137.
26. Buch SC, Nazar-Stewart V, Weissfeld JL et al (2008). Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes. Head Neck 30: 1139 1147.
27. Califano J, Westra WH, Meininger G et al (2000). Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 6: 347 352.
28. Carmeliet P, Jain RK (2000). Angiogenesis in cancer and other diseases. Nature 407: 249 257.
29. Carpenter JM, Syms MJ, Sniezek JC (2005). Oral carcinoma associated with betel nut chewing in the Pacific: an impending crisis? Pac Health Dialog 12: 158 162.
30. Chen YJ, Chang JT, Liao CT et al (2008). Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 99: 1507 1514.
31. Cheong SC, Chandramouli GV, Saleh A et al (2009). Gene expression in human oral squamous cell carcinoma is influenced by risk factor exposure. Oral Oncol. Jan 13. [Epub ahead of print].
32. Chiang WF, Liu SY, Yen CY et al (2008). Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas. Oral Oncol 44: 270 276.
33. Chiesa F, Sala L, Costa L et al (1986). Excision of oral leukoplakias by CO2 laser on an out-patient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumori 72: 307 312.
34. Chiu CF, Tsai MH, Tseng HC et al (2008a). A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 582 586.
35. Chiu CF, Tsai MH, Tseng HC et al (2008b). A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 898 902.
36. Cogliano V, Straif K, Baan R et al (2004). Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol 5: 708.
37. Cortesina G, Martone T, Galeazzi E et al (2000). Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer 89: 286 292.
38. Cruz IB, Snijders PJ, Meijer CJ et al (1998). p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 184: 360 368.
39. D'Souza G, Kreimer AR, Viscidi R et al (2007). Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944 1956.
40. Datta S, Majumder M, Biswas NK et al (2007). Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus. Cancer 110: 1991 1999.
41. Derka S, Vairaktaris E, Papakosta V et al (2006). Cell proliferation and apoptosis culminate in early stages of oral oncogenesis. Oral Oncol 42: 540 550.
42. Dikshit RP, Ramadas K, Hashibe M et al (2006). Association between diabetes mellitus and pre-malignant oral diseases: a cross sectional study in Kerala, India. Int J Cancer 118: 453 457.
43. Diniz-Freitas M, García-Caballero T, Antúnez-López J et al (2006). Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 42: 190 200.
44. Drummond SN, De Marco L, Pordeus Ide A et al (2002). TP53 codon 72 polymorphism in oral squamous cell carcinoma. Anticancer Res 22: 3379 3381.
45. Duarte EC, Ribeiro DC, Gomez MV et al (2008). Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression. Anticancer Res 28: 1101 1106.
46. Dye BA, Wang R, Lashley R et al (2007). Using NHANES oral health examination protocols as part of an esophageal cancer screening study conducted in a high-risk region of China. BMC Oral Health 17: 7 10.
47. Fasanmade A, Kwok E, Newman L (2007). Oral squamous cell carcinoma associated with khat chewing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104: e53 e55.
48. Fialka F, Gruber RM, Hitt R et al (2008). CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma - a pilot study. Oral Oncol 44: 941 948.
49. Fischer DJ, Epstein JB, Morton TH et al (2004). Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions. J Oral Pathol Med 33: 65 70.
50. Fischer DJ, Epstein JB, Morton TH Jr et al (2005). Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients. Oral Oncol 41: 489 496.
51. Franzmann EJ, Weed DT, Civantos FJ et al (2001). A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression. Otolaryngol Head Neck Surg 124: 426 432.
52. Franzmann EJ, Reategui EP, Carraway KL et al (2005). Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev 14: 735 739.
53. Friedrich RE, Bartel-Friedrich S, Plambeck K et al (1997). P53 auto-antibodies in the sera of patients with oral squamous cell carcinoma. Anticancer Res 17: 3183 3184.
54. Gabriel HE, Crott JW, Ghandour H et al (2006). Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr 83: 835 841.
55. Garavello W, Giordano L, Bosetti C et al (2008). Diet diversity and the risk of oral and pharyngeal cancer. Eur J Nutr 47: 280 284.
56. Giebułtowicz J, Wroczyński P, Piekarczyk J et al (2008). Fluorimetric detection of aldehyde dehydrogenase activity in human tissues in diagnostic of cancers of oral cavity. Acta Pol Pharm 65: 81 84.
57. Glazer CA, Chang SS, Ha PK et al (2008). Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncol. Jul 30. [Epub ahead of print].
58. Gottschlich S, Folz BJ, Goeroegh T et al (1999). A new prognostic indicator for head and neck cancer - p53 serum antibodies? Anticancer Res 19: 2703 2705.
59. Goutzanis L, Vairaktaris E, Yapijakis C et al (2007). Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. Oral Oncol 43: 165 173.
60. Guh JY, Chen HC, Tsai JF et al (2007). Betel-quid use is associated with heart disease in women. Am J Clin Nutr 85: 1229 1235.
61. Guha N, Boffetta P, Wünsch Filho V et al (2007). Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol 166: 1159 1173.
62. Guo Z, Yamaguchi K, Sanchez-Cespedes M et al (2001). Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clin Cancer Res 7: 1963 1968.
63. Gupta R, Sharma SC, Das SN (2008). Association of TNF-alpha and TNFR1 promoters and 3′ UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol 44: 455 463.
64. Ha PK, Chang SS, Glazer CA et al (2008). Molecular techniques and genetic alterations in head and neck cancer. Oral Oncol. Jul 30. [Epub ahead of print].
65. Haddad RI, Shin DM (2008). Recent advances in head and neck cancer. New Engl J Med 359: 1143 1154.
66. Haddad R, Crum C, Chen Z et al (2008). HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncol 44: 812 815.
67. Hamidi S, Salo T, Kainulainen T et al (2000). Expression of alpha(v)beta6 integrin in oral leukoplakia. Br J Cancer 82: 1433 1440.
68. Hashibe M, Straif K, Tashkin DP et al (2005). Epidemiologic review of marijuana use and cancer risk. Alcohol 35: 265 275.
69. Hashibe M, McKay JD, Curado MP et al (2008). Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet 40: 707 709.
70. Hashibe M, Brennan P, Chuang SC et al (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18: 541 550.
71. Hatagima A, Costa EC, Marques CF et al (2008). Glutathione S-transferase polymorphisms and oral cancer: a case-control study in Rio de Janeiro, Brazil. Oral Oncol 44: 200 207.
72. Hein DW, Doll MA, Fretland AJ et al (2000). Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9: 29 42.
73. Hirota SK, Braga FP, Penha SS et al (2008). Risk factors for oral squamous cell carcinoma in young and older Brazilian patients: a comparative analysis. Med Oral Patol Oral Cir Bucal 13: E227 E231.
74. Hoffmann D, Hoffmann I (1997). The changing cigarette, 1950-1995. J Toxicol Environ Health 50: 307 364.
75. Holmes L Jr, Desvignes-Kendrick M, Slomka J et al (2008). Is dental care utilization associated with oral cavity cancer in a large sample of community-based United States residents? Community Dent Oral Epidemiol. Nov 19. [Epub ahead of print].
76. Holmstrup P, Vedtofte P, Reibel J et al (2007). Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med 36: 262 266.
77. van Houten VM, Tabor MP, van den Brekel MW et al (2000a). Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions. Clin Cancer Res 6: 3803 3816.
78. van Houten VM, van den Brekel MW, Denkers F et al (2000b). Molecular diagnosis of head and neck cancer. Recent Results Cancer Res 157: 90 106.
79. Hu S, Li Y, Wang J, Xie Y et al (2006). Human saliva proteome and transcriptome. J Dent Res 85: 1129 1133.
80. Hu S, Loo JA, Wong DT (2007). Human saliva proteome analysis. Ann N Y Acad Sci 1098: 323 329.
81. Hu S, Arellano M, Boontheung P et al (2008). Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14: 6246 6252.
82. IARC (2004). GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide (2002 estimates).
83. Izzo JG, Papadimitrakopoulou VA, Liu DD et al (2003). Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst 95: 198 205.
84. Jacob BJ, Straif K, Thomas G et al (2004). Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol 40: 697 704.
85. Johnson N (2001). Tobacco use and oral cancer: a global perspective. J Dent Educ 65: 328 339.
86. Kannan S, Tahara H, Yokozaki H et al (1997). Telomerase activity in premalignant and malignant lesions of human oral mucosa. Cancer Epidemiol Biomarkers Prev 6: 413 420.
87. Karabulut A, Reibel J, Therkildsen MH et al (1995). Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 24: 198 200.
88. Kim HR, Christensen R, Park NH et al (2001). Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ. Clin Cancer Res 7: 3079 3086.
89. Kuratomi Y, Kumamoto M, Kidera K et al (2006). Diffuse expression of laminin gamma2 chain in disseminating and infiltrating cancer cells indicates a highly malignant state in advanced tongue cancer. Oral Oncol 42: 73 76.
90. Kurkivuori J, Salaspuro V, Kaihovaara P et al (2007). Acetaldehyde production from ethanol by oral streptococci. Oral Oncol 43: 181 186.
91. La Vecchia C (2009). Mouthwash and oral cancer risk: an update. Oral Oncol 45: 198 200.
92. La Vecchia C, Lucchini F, Negri E et al (2004). Trends in oral cancer mortality in Europe. Oral Oncol 40: 433 439.
93. Lee JJ, Hong WK, Hittelman WN et al (2000). Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 6: 1702 1710.
94. Lin YC, Huang HI, Wang LH et al (2008). Polymorphisms of COX-2-765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population. Oral Oncol 44: 798 804.
95. Lingen MW, Kalmar JR, Karrison T et al (2008). Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 44: 10 22.
96. Lippman SM, Hong WK (1989). Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17: 691 694.
97. Llewellyn CD, Johnson NW, Warnakulasuriya KA (2001). Risk factors for squamous cell carcinoma of the oral cavity in young people - a comprehensive literature review. Oral Oncol 37: 401 418.
98. Losi-Guembarovski R, Cólus IM, De Menezes RP et al (2008). Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population. Anticancer Res 28: 1023 1028.
99. Lucenteforte E, Garavello W, Bosetti C et al (2008). Dietary factors and oral and pharyngeal cancer risk. Oral Oncol. Nov 4. [Epub ahead of print].
100. Luzar B, Poljak M, Marin IJ et al (2004). Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis. Histopathology 45: 13 19.
101. Maass JD, Gottschlich S, Goeroegh T et al (1997). Head and neck cancer and p53-immunogenicity. Anticancer Res 17: 2873 2874.
102. Majumder M, Sikdar N, Ghosh S et al (2007). Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer 120: 2148 2156.
103. Marques CF, Koifman S, Koifman RJ et al (2006). Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol 42: 632 637.
104. Maserejian NN, Giovannucci E, Rosner B et al (2006). Prospective study of fruits and vegetables and risk of oral premalignant lesions in men. Am J Epidemiol 164: 556 566.
105. Maserejian NN, Giovannucci E, Rosner B et al (2007). Prospective study of vitamins C, E, and A and carotenoids and risk of oral premalignant lesions in men. Int J Cancer 120: 970 977.
106. Máthé M, Suba Z, Németh Z et al (2006). Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncol 42: 493 500.
107. Matsuda T, Yabushita H, Kanaly RA et al (2006). Increased DNA damage in ALDH2-deficient alcoholics. Chem Res Toxicol 19: 1374 1378.
108. McCullough MJ, Farah CS (2008). The role of alcohol in oral carcinogenesis with particular reference to alcohol-containing mouthwashes. Aust Dent J 53: 302 305.
109. Merchant A, Husain SS, Hosain M et al (2000). Paan without tobacco: an independent risk factor for oral cancer. Int J Cancer 86: 128 131.
110. Meyer MS, Joshipura K, Giovannucci E et al (2008). A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control 19: 895 907.
111. Mithani SK, Mydlarz WK, Grumbine FL et al (2007). Molecular genetics of premalignant oral lesions. Oral Dis 13: 126 133.
112. Molinolo AA, Amornphimoltham P, Squarize CH et al (2008). Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol. Sep 18. [Epub ahead of print].
113. Moore S, Johnson N, Pierce A et al (1999). The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis 5: 185 195.
114. Moore SR, Johnson NW, Pierce AM et al (2000a). The epidemiology of tongue cancer: a review of global incidence. Oral Dis 6: 75 84.
115. Moore SR, Johnson NW, Pierce AM et al (2000b). The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6: 65 74.
116. Mutirangura A, Supiyaphun P, Trirekapan S et al (1996). Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res 56: 3530 3533.
117. Muto M, Hitomi Y, Ohtsu A et al (2000). cetaldehyde production by non-pathogenic Neisseria in human oral microflora: implications for carcinogenesis in upper aerodigestive tract. Int J Cancer 88: 342 350.
118. Muwonge R, Ramadas K, Sankila R et al (2008). Role of tobacco smoking, chewing and alcohol drinking in the risk of oral cancer in Trivandrum, India: a nested case-control design using incident cancer cases. Oral Oncol 44: 446 454.
119. Park NJ, Zhou X, Yu T et al (2007). Characterization of salivary RNA by cDNA library analysis. Arch Oral Biol 52: 30 35.
120. Park S, Bae J, Nam BH et al (2008). Aetiology of cancer in Asia. Asian Pac J Cancer Prev 9: 371 380.
121. Patel V, Leethanakul C, Gutkind JS (2001). New approaches to the understanding of the molecular basis of oral cancer. Crit Rev Oral Biol Med 12: 55 63.
122. Patel BP, Rawal UM, Rawal RM et al (2008). Tobacco, antioxidant enzymes, oxidative stress, and genetic susceptibility in oral cancer. Am J Clin Oncol 31: 454 459.
123. Pavia M, Pileggi C, Nobile CG et al (2006). ssociation between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. Am J Clin Nutr 83: 1126 1134.
124. Pelucchi C, Talamini R, Negri E et al (2003). Folate intake and risk of oral and pharyngeal cancer. Ann Oncol 14: 1677 1681.
125. Pelucchi C, Gallus S, Garavello W et al (2008). Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 17: 340 344.
126. Petti S (2008). Lifestyle risk factors for oral cancer. Oral Oncol [Epub ahead of print].
127. Pickering V, Jordan RC, Schmidt BL (2007). Elevated salivary endothelin levels in oral cancer patients - a pilot study. Oral Oncol 43: 37 41.
128. Proia NK, Paszkiewicz GM, Nasca MA et al (2006). Smoking and smokeless tobacco-associated human buccal cell mutations and their association with oral cancer - a review. Cancer Epidemiol Biomarkers Prev 15: 1061 1077.
129. Pu X, Lippman SM, Yang H et al (2009). Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions. Cancer 2009 Feb 5. [Epub ahead of print].
130. Reategui EP, de Mayolo AA, Das PM et al (2007). Characterization of CD44v3-containing isoforms in head and neck cancer. Cancer Biol Ther 5: 1163 1168.
131. Reibel J (2003). Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 14: 47 62.
132. Reichart PA, Nguyen XH (2008). Betel quid chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med 37: 511 514.
133. Richie JP Jr, Kleinman W, Marina P et al (2008). Blood iron, glutathione, and micronutrient levels and the risk of oral cancer. Nutr Cancer 60: 474 482.
134. Rodriguez T, Altieri A, Chatenoud L et al (2004). Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol 40: 207 213.
135. Roepman P, Wessels LF, Kettelarij N et al (2005). An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37: 182 186.
136. Rossi M, Garavello W, Talamini R et al (2007). Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiol Biomarkers Prev 16: 1621 1625.
137. Santhi WS, Sebastian P, Varghese BT et al (2006). NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins. Exp Mol Pathol 81: 123 130.
138. Sanz-Ortega J, Roig F, Al-Mousa MM et al (2007). 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer. Histol Histopathol 22: 541 545.
139. Sapkota A, Hsu CC, Zaridze D et al (2008). Dietary risk factors for squamous cell carcinoma of the upper aerodigestive tract in central and eastern Europe. Cancer Causes Control 19: 1161 1170.
140. Sawair FA, Al-Mutwakel A, Al-Eryani K et al (2007). High relative frequency of oral squamous cell carcinoma in Yemen: qat and tobacco chewing as its aetiological background. Int J Environ Health Res 17: 185 195.
141. Scheer M, Kuebler AC, Zöller JE (2004). Chemoprevention of oral squamous cell carcinomas. Onkologie 27: 187 193.
142. Schwartz SM, Doody DR, Fitzgibbons ED et al (2001). Oral squamous cell cancer risk in relation to alcohol consumption and alcohol dehydrogenase-3 genotypes. Cancer Epidemiol Biomarkers Prev 10: 1137 1144.
143. Scully C (1995). Oral precancer: preventive and medical approaches to management. Eur J Cancer B Oral Oncol 31B: 16 26.
144. Scully C (2002). Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol 38: 227 234.
145. Scully C (2005). Oral cancer; the evidence for sexual transmission. Br Dent J 199: 203 207.
146. Scully C, Bedi R (2000). Ethnicity and oral cancer. Lancet Oncol 1: 37 42.
147. Scully C, Moles D (2008). Oral cancer. In: Heggenhougen KH, Quah S, eds Encyclopedia of public health. Vol 4. San Diego, CA: Academic Press, pp. 668 677.
148. Scully C, Field JK, Tanzawa H (2000a). Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36: 256 263.
149. Scully C, Field JK, Tanzawa H (2000b). Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 36: 311 327.
150. Scully C, Field JK, Tanzawa H (2000c). Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications. Oral Oncol 36: 404 413.
151. Scully C, Sudbø J, Speight PM (2003). Progress in determining the malignant potential of oral lesions. J Oral Pathol Med 32: 251 256.
152. Seitz HK, Cho CH (2009). Contribution of alcohol and tobacco use in gastrointestinal cancer development. Methods Mol Biol 472: 217 241.
153. Seitz HK, Stickel F (2007). Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7: 599 612.
154. Serefoglou Z, Yapijakis C, Nkenke E et al (2008). Genetic association of cytokine DNA polymorphisms with head and neck cancer. Oral Oncol 44: 1093 1099.
155. Shaw RJ, Liloglou T, Rogers SN et al (2006). Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 94: 561 568.
156. Shaw RJ, Hall GL, Woolgar JA et al (2007). Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 45: 617 622.
157. Shillitoe EJ (2008). The role of viruses in squamous cell carcinoma of the oropharyngeal mucosa. Oral Oncol. Oct 24. [Epub ahead of print].
158. Shpitzer T, Bahar G, Feinmesser R et al (2007). A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol 133: 613 617.
159. Slaughter DP, Southwick HW, Smejkal W (1953). Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963 968.
160. Solomon PR, Selvam GS, Shanmugam G (2008). Polymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of Indians. Oral Dis 14: 633 639.
161. Sridhar S, Schembri F, Zeskind J et al (2008). Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics 9: 259.
162. Sumida T, Hamakawa H, Sogawa K et al (1999). Telomerase components as a diagnostic tool in human oral lesions. Int J Cancer 80: 1 4.
163. Sun W, Zhou S, Chang SS et al (2009). Mitochondrial mutations contribute to HIF1alpha accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenase kinase 2 in head and neck squamous cell carcinoma. Clin Cancer Res 15: 476 484.
164. Suzuki T, Wakai K, Matsuo K et al (2006). Effect of dietary antioxidants and risk of oral, pharyngeal and laryngeal squamous cell carcinoma according to smoking and drinking habits. Cancer Sci 97: 760 767.
165. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ et al (2004). Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 10: 3607 3613.
166. Takeshima M, Saitoh M, Kusano K et al (2008). High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka. J Oral Pathol Med 37: 475 479.
167. Tavassoli M, Brunel N, Maher R et al (1998). p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int J Cancer 78: 390 391.
168. Tezal M, Sullivan MA, Reid ME et al (2007). Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg 133: 450 454.
169. Thomas SJ, Bain CJ, Battistutta D et al (2007). Betel quid not containing tobacco and oral cancer: a report on a case-control study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer 120: 1318 1323.
170. Thomas SJ, Harris R, Ness AR et al (2008). Betel quid not containing tobacco and oral leukoplakia: a report on a cross-sectional study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer 123: 1871 1876.
171. Thomson PJ (2002). Field change and oral cancer: new evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg 31: 262 266.
172. Thomson PJ, Hamadah O (2007). Cancerisation within the oral cavity: the use of 'field mapping biopsies' in clinical management. Oral Oncol 43: 20 26.
173. Thongprasom K, Mutirangura A, Cheerat S (1998). Telomerase activity in oral lichen planus. J Oral Pathol Med 27: 395 398.
174. Tjebbes GW, Leppers vd Straat FG, Tilanus MG et al (1999). p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases. Oral Oncol 35: 384 389.
175. Trullenque-Eriksson A, Muñoz-Corcuera M, Campo-Trapero J et al (2009). Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med Oral Patol Oral Cir Bucal. Feb 16. [Epub ahead of print].
176. Tsai YS, Lee KW, Huang JL et al (2008). Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells. Toxicology 249: 230 237.
177. Vallecillo Capilla M, Romero Olid MN, Olmedo Gaya MV et al (2007). Factors related to survival from oral cancer in an Andalusian population sample (Spain). Med Oral Patol Oral Cir Bucal 12: E518 E523.
178. Varela-Lema L, Taioli E, Ruano-Ravina A et al (2008). Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med 10: 369 384.
179. Viet CT, Jordan RC, Schmidt BL (2007). DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer. J Calif Dent Assoc 35: 844 849.
180. Vigneswaran N, Tilashalski K, Rodu B et al (1995). Tobacco use and cancer. A reappraisal. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80: 178 182.
181. van der Waal I (2008). Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2008 Jul 30. [Epub ahead of print].
182. Wang J, Henry S, Yu T et al (2006). Salivary oral cancer transcriptome biomarkers (SOCTB) for clinical detection 35th Annual Meeting of the American Association for Dental Research. Abstract #218.
183. Wang Y, Spitz MR, Lee JJ et al (2007). Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res 13: 3753 3758.
184. Warnakulasuriya S (2000). Lack of molecular markers to predict malignant potential of oral precancer. J Pathol 190: 407 409.
185. Warnakulasuriya S (2008). Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008 Sep 17. [Epub ahead of print].
186. Warnakulasuriya KA, Ralhan R (2007). Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco - a review. J Oral Pathol Med 36: 63 77.
187. Winn DM (1995). Diet and nutrition in the etiology of oral cancer. Am J Clin Nutr 61: 437S 445S.
188. Wong DT (2006). Salivary diagnostics for oral cancer. J Calif Dent Assoc 34: 303 308.
189. Xie H, Onsongo G, Popko J et al (2008). Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics 7: 486 498.
190. Yajima Y, Noma H, Furuya Y et al (2004). Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma. Oral Oncol 40: 314 320.
191. Ye Y, Lippman SM, Lee JJ et al (2008). Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer 113: 2488 2495.
192. Yokoyama A, Omori T (2003). Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn J Clin Oncol 33: 111 121.
193. Yokoyama A, Tsutsumi E, Imazeki H et al (2007a). Contribution of the alcohol dehydrogenase-1B genotype and oral microorganisms to high salivary acetaldehyde concentrations in Japanese alcoholic men. Int J Cancer 121: 1047 1054.
194. Yokoyama A, Tsutsumi E, Imazeki H et al (2008). Salivary acetaldehyde concentration according to alcoholic beverage consumed and aldehyde dehydrogenase-2 genotype. Alcohol Clin Exp Res 32: 1607 1614.
195. Zain RB (2001). Cultural and dietary risk factors of oral cancer and precancer - a brief overview. Oral Oncol 37: 205 210.
196. Zavras AI, Wu T, Laskaris G et al (2002). Interaction between a single nucleotide polymorphism in the alcohol dehydrogenase 3 gene, alcohol consumption and oral cancer risk. Int J Cancer 97: 526 530.
197. Zhang L, Williams M, Poh CF et al (2005). Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 65: 8017 8021.
198. Zheng TZ, Boyle P, Hu HF et al (1990). Dentition, oral hygiene, and risk of oral cancer: a case-control study in Beijing, People's Republic of China. Cancer Causes Control 1: 235 241.
199. Zhong LP, Zhang CP, Zheng JW et al (2007). Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients. Arch Oral Biol 52: 1079 1087.
200. Zhuo W, Wang Y, Zhuo X et al (2009). CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Invest 27: 86 95.
201. Zimmermann BG, Park NJ, Wong DT (2007). Genomic targets in saliva. Ann N Y Acad Sci 1098: 184 191.